Drug Evaluation Committee eCTD v4.0 Educational Material Version 2 is now available.
Electronic Information Subcommittee
November 2024
Task Force 1 eSubmission (Promotion and Efficiency of Electronic Submission of Applications for Approval) of the Drug Evaluation Committee's Electronic Information Subcommittee prepared and published the " eCTD v4.0 Educational Material" in March 2023 to assist companies with internal education (awareness) and process review necessary for reference submissions and applications for approval using eCTD v4. 0 Educational Materials " was prepared and published.
In FY2024, less than two years before the complete transition to eCTD v4 in April 2026, we believe that companies that produce eCTD in-house are now in the process of implementing the system, while companies that outsource the system are now considering specific methods. Based on these decisions, we have created the "eCTD v4.0 Educational Materials, Second Edition" to explain the features of v4. The purpose of this document has been changed from the previous version, and it is intended for use by those who lead the creation of eCTD at their companies and those who lead the implementation of v4 for their own staff in charge of the practical implementation.
The materials are available in both PowerPoint and PDF formats. The PowerPoint file may be adapted and used at your convenience, and the PDF file has been prepared to facilitate review of the content prepared as TF1.
Japan Pharmaceutical Manufacturers Association, Committee on Drug Evaluation
Electronic Information Subcommittee 2024 Task Force 1
Deliverables of the Drug Evaluation Committee Return to list of all deliverables